UniDoc Health Corp. to Participate in Ukraine Recovery Conference (URC2025)
VANCOUVER, BC / / July 9, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) is pleased to announce that it was invited to participate in and will attend the Ukraine Recovery Conference (URC2025), jointly hosted by Italy and Ukraine, scheduled for July 10-11, 2025, in Rome, Italy. The conference follows a series of international high-level events aimed at mobilizing global support for Ukraine's reconstruction, modernization, and reform.
Key Features:
UniDoc attending Ukraine Recovery Conference ("URC2025") in Rome, July 10-11, 2025.
Opportunity to highlight successful deployment and impact of AI-powered* H3 Health Cubes in Ukraine.
Conference provides platform for potential collaboration and investment opportunities supporting Ukraine's reconstruction.
"We are honored to participate in the Ukraine Recovery Conference and to further support global efforts aimed at the recovery and modernization of Ukraine," said Tony Baldassarre, CEO of UniDoc Health Corp. "Our recent deployment in Ukraine exemplify our commitment to enhancing healthcare accessibility and resilience through innovative eHealth solutions. We invite conference attendees interested in learning more or exploring collaborative opportunities to reach out directly."
UniDoc's presence at URC2025 highlights the Company's ongoing commitment to providing innovative healthcare solutions during critical times, exemplified by its recent deployment of AI-powered H3 Health Cubes to Ukraine, where they continue to enhance frontline healthcare capabilities.
The URC2025 will gather political leaders, international financial institutions, private sector representatives, and civil society members to address the urgent recovery and investment needs of Ukraine. Key themes include private sector involvement, human capital development, regional initiatives, and reforms aligned with Ukraine's European Union accession goals. The conference is being held at Roma Convention Center La Nuvola. Additional information about the conference can be accessed at www.urc-international.com.
UniDoc's participation offers an important opportunity to showcase its contributions to healthcare innovation and international humanitarian efforts, including the shipment of the first AI-equipped* H3 Health Cube at Yasinia Regional Hospital in Ukraine.
Attendees interested in scheduling a meeting with UniDoc representatives during URC2025 are encouraged to contact the company via email at info@unidoctor.com.
On Behalf of the Board of Directors,
~Antonio (Tony) Baldassarre~
Antonio BaldassarreCEO, President & DirectorUniDoc Health Corp.
About UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)
UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.
* AI refers to advanced artificial intelligence - the ability of the software to provide recommendations personalized to an individual's needs. UniDoc's NEIL Connect allows for the integration of advanced AI, through partnered software abilities, including AI used for patient intake/triage and AI used for patient monitoring.
For further information, please contact:
UniDoc Investor RelationsTel: +1 778.383.6731Email: info@unidoctor.com
Matt Chatterton, DirectorTel: +1 778.613.2082Email: matt@unidoctor.com
Media Inquiries media@unidoctor.com
Forward-Looking Statements
This news release contains statements and information that, to the extent that they are not historical fact, may constitute "forward-looking information" within the meaning of applicable securities legislation. Forward-looking information may include financial and other projections, as well as statements regarding future plans, objectives, or economic performance, or the assumption underlying any of the foregoing. In some cases, forward-looking statements can be identified by terms such as "may", "would", "could", "will", "will be", "likely", "except", "anticipate", "believe", "intend", "plan", "forecast", "project", "estimate", "outlook", or the negative thereof or other similar expressions concerning matters that are not historical facts. Examples of such statements include, but are not limited to, statements with respect to the Company's participation in URC2025 and the expected attendees at the conference.
Forward-looking information is based on the assumptions, estimates, analysis, and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect. The material factors and assumptions used to develop the forward-looking information contained in this news release include, but are not limited to, key personnel and qualified employees continuing their involvement with the Company; the Company's ability to secure additional financing on reasonable terms; the competitive conditions of the industries in which the Company operates; and laws and any amendments thereto applicable to the Company.
Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking information, including, without limitation, risks relating to the future business plans of the Company; risks that the Company will not be able to retain its key personnel; risks that the Company will not be able to secure financing on reasonable terms or at all; as well as all of the other risks as described in the Company's annual management discussion and analysis dated July 31, 2024 under the heading "Risks Factors." Accordingly, readers should not place undue reliance on any such forward-looking information.
Further, any forward-looking information speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company's management to predict all such factors and to assess in advance the impact of each such factor on the Company's business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The Company does not undertake any obligation to update any forward-looking information to reflect information or events after the date on which it is made or to reflect the occurrence of unanticipated events, except as required by law, including securities laws.
The CSE does not accept responsibility for the adequacy or accuracy of this release.
SOURCE: UniDoc Health Corp.
View the original press release on ACCESS Newswire
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
28 minutes ago
- Wall Street Journal
‘Nobody Sits Like the French' Review: The Chair That Charmed Paris
One could argue that there is no better vantage point for dedicated people-watching than from a rattan bistro chair on the bustling terrace of a Parisian cafe. Maison Louis Drucker, established in 1885 by a Polish expatriate, is the oldest surviving rattan-seat manufacturer in France. Its diverse wares (a dozen of which are pictured above) are crafted from thick lengths of rattan bent around beechwood frames to create a paragon of posterior satisfaction. The original bistro chair was developed in 1859 by the German-Austrian cabinetmaker Michael Thonet (pronounced like bonnet), who discovered how to bend strong wood into graceful shapes using hot steam. His No. 14 chair first captured the world's attention at the Paris Exposition of 1867. Its iconic status is one of the topics explored in 'Nobody Sits Like the French,' Charles Pappas's sprightly yet authoritative history of the seven universal expositions held in Paris between 1855 and 1937. The No. 14 chair is emblematic of the book's broader survey of how the expositions fostered innovations at both micro and macro levels. What began as everyday items—cafe seats, Louis Vuitton trunks and Roquefort cheese—would become enduring classics, fit to stand alongside engineering marvels like the Eiffel Tower and the Grand Palais. The No. 14 chair cemented its reputation when it won a coveted gold medal at the 1867 fair, which drew more than 15 million visitors. 'From that moment on its fame spread with the quickness of a meme,' writes Mr. Pappas with customary éclat. Thonet's chair—considered to be the first piece of mass-produced furniture—could be shipped in parts: 36 disassembled chairs fit into an approximately 36-cubic-foot crate, making it ideal for cafes and bistros. The chair, under the name 214, is still produced by the Thonet company in Frankenberg, Germany. It remains a masterpiece of reduction, consisting of only six wooden elements, 10 screws and two nuts. In 1925 Le Corbusier, the celebrated Swiss-French designer, even gave it his seal of approval: 'Never was a better and more elegant design and a more precisely crafted and practical item created.'
Bloomberg
31 minutes ago
- Bloomberg
UK to Invest €163 Million in Europe's Starlink Rival Eutelsat
Eutelsat Communications SA, the European competitor to Elon Musk's Starlink, said that the UK government will invest €163.3 million ($191 million), joining a France-led round into the company last month. The additional funds bring the amount the low-Earth-orbit satellite company has raised to €1.5 billion, the company said in a statement on Thursday. The French government, Bharti Space, CMA CGM and Fonds Stratégique de Participations announced they would invest €1.35 billion last month in a deal to help the company build out its fleet of satellites.
Yahoo
32 minutes ago
- Yahoo
Analyst Explains Why Uber Technologies (UBER) Stock Can Grow More Despite 50% Year-to-Date Gains
Uber Technologies, Inc. (NYSE:UBER) is one of the . Mark Mahaney, Evercore ISI head of internet research, explained in a recent program on CNBC that Uber Technologies (NYSE:UBER) needs to expand in more geographies for growth via partnerships 'If you get more of these rollouts with Waymo, and you get other AV companies—there's more than just, you know, it's not just Waymo's world and it's not just Tesla's world. And by the way, of those two, Waymo is dramatically better in terms of what they've been able to show and roll out so far. But if you get Zoox in the market, and then you get a couple of Chinese players—not in the US but in parts of the Middle East, maybe in Europe—and if you get more companies like Mobileye, Mobilewave, if you get these companies out there showing that you can get multiple AV vendors, maybe not two or three but maybe four, five, or six, that's better for Uber's economics.' The analyst thinks there's still more room for Uber Technologies (NYSE:UBER) stock to grow: 'I think there's a lot more room for Uber stock. I know it's up 50% year to date, but this thing trades at like 18–19 times free cash flow. It should trade at 25 times free cash flow. They're growing their free cash flow 25% to 30%.' Hinde Group stated the following regarding Uber Technologies, Inc. (NYSE:UBER) in its Q1 2025 investor letter: 'With operations in more than 10,000 cities across 72 countries and gross bookings expected to exceed $180 billion this year, Uber Technologies, Inc. (NYSE:UBER) is one of the largest transportation network companies in the world. Each month, Uber helps more than 170 million users meet their mobility and delivery needs by connecting them with more than 7 million independent drivers and couriers. Uber's mobility and delivery services are enabled by a highly sophisticated and efficient technology platform that automatically manages and optimizes demand prediction, matching & dispatching, routing, pricing, and personalization, among other functions. Uber has a leading category position in eight of its top ten mobility and delivery markets. While we acknowledge the potential of UBER as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
